2026-08-12 · 2026-08 / week-2
Core AI Prices an AI Pivot Above a 47% ATM
Core AI Prices an AI Pivot Above a 47% ATM
Summary: Core AI Holdings (CHAI) filed an August 11 at-the-market supplement allowing up to $3.539 million of common-stock sales. At the supplement's $0.33 reference price, the filing illustrates 12.085 million potential new shares against 25.867 million common shares outstanding, or 46.7% of the filed denominator. The latest available market snapshot was $0.3192 at 2026-08-11 21:35 UTC, with 672,386 shares traded. Core AI's latest audited filing reported $1.931 million of cash, $6.651 million of 2025 operating cash use, and a $31.964 million accumulated deficit. Nasdaq also notified the company of a minimum-bid deficiency, with an initial cure date of January 27, 2027. The mispricing is an inference, not a fact: the quote appears to assign value to an AI and high-performance-computing pivot before a new operating or cash bridge exists, while the ATM is still only potential supply. This is a conditional U.S. common-stock Short Watchlist, not an executable trade or personalized financial advice.
Research timestamp: 2026-08-12 06:40:52 Singapore time, UTC+08:00. The latest available U.S. market snapshot was $0.3192 at 2026-08-11 21:35:00 UTC, or 2026-08-12 05:35:00 Singapore time. It is an after-hours reference from the available finance feed, not a verified regular-session entry.
Evidence labels: The August 11 prospectus supplement, May 15 audited 20-F, and the market snapshot are reported facts. The claim that the market is pricing an AI pivot before a cash bridge is a high-confidence inference from the filing sequence and price, not a directly observed expectation. The target prices and probabilities are judgmental scenarios. Actual ATM sales, borrow, short interest, options, dealer flow, fund flow, NBBO spread, order-book depth, venue quality, and exit liquidity were not independently verified.
Opportunity Ranking
This run was limited to U.S. market short opportunities. I screened the current articles/2026-08/week-2/ folder and the full repository by ticker, issuer, financing mechanism, ATM, registered resale, pre-funded warrants, going-concern language, and listing deficiency. No prior article for CHAI, EDBL, or BNZI was found. The research used creative filing combinations such as "at-the-market AI pivot going concern Nasdaq bid deficiency", "registered resale pre-funded warrants cash burn reverse split August", "ATM public float one-third shelf operating cash use", and "AI infrastructure equity capacity current denominator". These searches were designed to find a mismatch between capital access, usable cash, and the common denominator rather than a generic earnings list.
| Rank | Idea | Lane | Fresh market level and evidence | Catalyst window | Greater-than-5% move case | Why it ranked here | Reject or lower-rank reason |
|---|---|---|---|---|---|---|---|
| 1 | CHAI short | U.S. microcap / AI and HPC pivot / ATM / listing clock | $0.3192, down 4.617%, latest available trade 2026-08-11 21:35 UTC; volume 672,386. Fresh 424B5 permits $3.539M of ATM sales, with 25.867M shares outstanding before the assumed sale. | First ATM sale or no-sale disclosure, next cash and share-count filing, and Nasdaq compliance updates through January 27, 2027 | A first sale at a weak price, no operating proof, or listing pressure can push the quote lower. AI funding, a reverse split, or a strategic partner can produce a sharp squeeze. | It has the cleanest current bridge between a new financing ceiling, a fresh filed denominator, an audited cash deficit, and a dated listing clock. | The ATM is not proof of issuance. The AI pivot may attract non-dilutive capital, and the thin tape can gap through any control. |
| 2 | EDBL short | U.S. microcap / ATM versus public float / going concern | $1.78, down 3.279%, latest available trade 2026-08-11 21:35 UTC; volume 78,433. Fresh 8-K and 424B5 disclose a $7.196M ATM. The March 31 10-Q reported $1.952M of cash, $7.727M of current liabilities, and a going-concern warning. | First ATM sale, next 10-Q, and cash and share-count reconciliation | At the reference price, full ATM capacity would be roughly 4.04M shares, but public-float and filed-share states do not reconcile cleanly. | The potential capacity is large relative to the finance-feed market-cap reference and the operating business is cash constrained. | Q1 operating cash flow was positive at $0.251M, the capacity is constrained by shelf rules, and the tape is too thin to treat a supply calculation as an executable short. |
| 3 | BNZI short | U.S. microcap / convertible resale / maturity pressure | $1.91 reference, up 10.169%, but the latest available trade was 2026-08-06 21:35 UTC, not current to this run. Fresh 424B5 registers up to 3.957M additional conversion and warrant shares. The March 31 10-Q reported $0.137M of cash and $5.501M of first-quarter operating cash use. | Actual resale or exercise, next cash and share-count filing, and note maturity or amendment | A documented resale or exercise could re-anchor the denominator. The low float and stale quote also create a large squeeze risk. | The filing evidence is strong and the cash bridge is weak. | The market snapshot is stale, the prior registration stack is large, and no locate, borrow, or resale evidence was verified. |
| 4 | SCWO short | U.S. microcap / ATM headline versus accessible shelf | $2.32, up 7.442%, latest available trade 2026-08-11 22:20:36 UTC; volume 70,953. The headline ATM is $50M, but the fresh filing indicates only about $1.142M of remaining baby-shelf availability after prior sales. | Actual sale under the remaining shelf capacity and next cash filing | The stock can still move on a sale or project headline, but the headline capacity is not accessible in full. | It is a useful false-positive control for the ATM screen. | The actual accessible supply is much smaller than the headline, and the capital-availability thesis is not strong enough for publication. |
CHAI wins because the mechanism is not simply “large ATM equals dilution.” It is a dated bridge problem: AI and HPC narrative to revenue, financing capacity to actual cash, potential shares to actual issuance, and listing deficiency to a corporate-action clock. EDBL has a larger potential capacity ratio, but its latest quarter contains a positive operating-cash result and a less clean denominator. BNZI has the strongest cash stress, but its quote is stale and its low-float squeeze risk is higher. SCWO fails the accessible-capacity test.
Geographic Search Audit
The user explicitly scoped this run to U.S. market shorts. I activated only the U.S. lane. Japan, broader Asia, Europe, and the U.K. were not presented as rejected candidates because expanding the screen beyond the requested geography would violate the task scope.
Why This Is the Best Opportunity Right Now
Strongest counterargument first: Core AI may be an early-stage capital-markets story rather than a failed operating company. The prospectus describes an expansion from Core Gaming into AI technology infrastructure and high-performance-computing data centers. A strategic investor, a customer contract, non-dilutive financing, or a credible partner could make the current ATM unnecessary. A reverse split or a successful ten-session bid-price cure could also create a mechanical rebound. The low nominal price and thin tape mean a short can lose quickly even if the financing thesis is correct.
That counterargument does not erase the current evidence boundary. The latest audited 20-F says Core AI has a limited operating history, an accumulated deficit of $31.964 million, and cash and cash equivalents of $1.931 million at December 31, 2025. It reported $6.651 million of consolidated operating cash use for 2025. The filing also says existing cash is insufficient to fully fund the business plan and includes a going-concern explanatory paragraph. Those facts do not prove failure. They do show that the AI and HPC pivot needs a new financing or operating bridge before it can be valued as an established infrastructure platform.
The fresh ATM supplement allows up to $3.539 million of common-stock sales through D. Boral Capital. At the filing's $0.33 August 10 closing-price assumption, the supplement illustrates 12.085 million shares after the offering, compared with 25.867 million shares outstanding on August 10. The potential issuance is therefore about 46.7% of the pre-offering denominator. At the latest available $0.3192 reference, the same dollar capacity would represent about 11.087 million shares, or 42.9% of the filed denominator. Both are stress calculations. Neither proves that one share has been sold.
The listing clock adds urgency but not certainty. Nasdaq notified the company that its bid price had stayed below $1.00 from June 17 through July 30, 2026. The initial compliance period runs to January 27, 2027, subject to the applicable Nasdaq process. This is a catalyst and squeeze risk. It is not evidence of current dilution. A reverse split can reset the displayed price while leaving the financing and operating claims unresolved.
Why This Can Jump or Dump More Than 5% Soon
Fact: The latest available snapshot showed CHAI at $0.3192, down 4.617%, with an intraday range of $0.3078 to $0.3327, an open of $0.3359, and 672,386 shares traded. The snapshot was outside regular U.S. hours. It establishes an observed reference, not an orderly market or a crowded short.
Downside inference: A filed ATM sale, a weak sale price, a next filing showing further cash use without an operating bridge, or a listing action that forces a reverse split could push the stock toward $0.24 or $0.12. A move to $0.24 is only a 24.8% gross short return from the reference, so borrow and execution costs matter. The lower target requires actual financing pressure or a failure to produce AI-related cash evidence, not the prospectus maximum by itself.
Upside inference: A strategic AI or HPC funding announcement, a signed customer or partner disclosure, a reverse-split vote or implementation that improves access to capital, or evidence that the ATM remains unused could push the stock toward $0.55 or beyond. That is a 72.3% mark-to-market loss for a short from the reference. The squeeze case is deliberately large because the instrument is a low-priced microcap.
Unknown: No live short interest, locate availability, borrow fee, recall terms, options chain, implied volatility, dealer flow, fund flow, NBBO spread, order-book depth, venue quality, or exit liquidity was independently verified. Volume alone cannot identify who is short, who is covering, or whether a fresh issuance can be absorbed.
What Should Surprise a Sophisticated Reader
The obvious headline is a $3.539 million ATM. The more useful surprise is that the financing has four different economic states:
- Authorization: The company may sell up to the stated aggregate amount through the sales agent.
- Potential shares: At the filing reference, the supplement illustrates 12.085 million new shares. This is a denominator stress test, not current float.
- Actual cash: No first sale or cash receipt was verified in this run. The ATM is not a $3.539 million cash balance.
- Operating runway: The latest audited cash and operating-cash figures predate the August financing and do not show that AI or HPC operations have begun funding themselves.
The listing deficiency is another state. It can force a corporate-action response, but it does not make the ATM shares more immediate. Treating the listing clock, financing capacity, and operating pivot as one dilution fact would overstate the short thesis.
The Setup
| State | Reported evidence | What it does not prove |
|---|---|---|
| AI and HPC pivot | The August 11 supplement describes expansion into AI technology infrastructure and high-performance-computing data centers | Revenue, contracted customers, data-center ownership, deployment timing, or positive operating cash flow |
| ATM | Up to $3.539M through D. Boral Capital; $0.33 filing reference; 12.085M illustrative shares | Actual issuance, actual proceeds, immediate float, or an executable short |
| Latest audited liquidity | $1.931M cash, $6.651M 2025 operating cash use, $31.964M accumulated deficit | Current August cash, current burn, or proof that the company cannot obtain new capital |
| Nasdaq deficiency | Minimum-bid notice, initial cure date January 27, 2027 | A completed reverse split, delisting, or certain share issuance |
| Current reference | $0.3192, after-hours finance snapshot, 672,386 volume | A verified regular-session quote, spread, depth, venue, borrow, or exit liquidity |
The short thesis therefore depends on the sequence, not on a single ratio. The next filing must show whether potential financing became actual cash and whether the company can produce operating evidence that supports the new narrative.
The Market Price
| Field | Observation |
|---|---|
| Latest available provider reference | $0.3192 |
| Provider timestamp | 2026-08-11 21:35:00 UTC, 2026-08-12 05:35:00 Singapore time |
| Daily change | -4.617% |
| Intraday range | $0.3078 to $0.3327 |
| Open | $0.3359 |
| Reported volume | 672,386 shares |
| Latest filed common denominator | 25,866,846 shares outstanding on August 10, 2026 |
| Filing ATM capacity | $3.539M |
| Illustrative shares at filing reference | 12,084,592 at $0.33 |
| Potential shares at current reference | About 11,087,159 at $0.3192 |
| ATM capacity versus filed denominator | About 46.7% at the filing reference, or 42.9% at the latest reference |
| Filing-based equity value at latest reference | About $8.26M, using the August 10 filed denominator |
| Clean current enterprise value | Not computed. The latest audited cash and debt bridge is December 31, 2025, while the market denominator is August 10, 2026. |
| Executable entry | None verified. Keep entry.price null and execution.can_execute false. |
The $0.33 price is an offering calculation input, not a floor. The $3.539 million is capacity, not cash received. The $8.26 million filing-based equity value is a price-only calculation, not a reconciled enterprise value. Keeping those states separate prevents the article from turning a prospectus stress test into an execution claim.
The Positioning
No live positioning claim is made. The down move and volume show active trading, but they do not prove high short interest, cheap borrow, forced covering, dealer support, or fund liquidation. The structural supply evidence is also incomplete because the ATM is authorized capacity, not actual issuance.
Positioning confidence is 3/5. The short is not executable without a verified locate, borrow cost, recall terms, same-session spread, depth, venue, volume quality, and exit liquidity. A strategic funding headline, reverse-split announcement, or borrow recall could move the price before the next cash filing.
The Catalyst
| Catalyst | Timing | What confirms the short thesis | What rejects it |
|---|---|---|---|
| First ATM activity | Any session after the August 11 supplement | A filing shows shares sold and cash received while the operating and listing bridge remains open | No sale is needed, the ATM is suspended, or non-dilutive capital funds the plan |
| Next cash and share-count filing | Next periodic report or financing disclosure | Cash remains thin, operating burn continues, and new shares or warrants increase the denominator without matching revenue | Cash, burn, actual shares, and a credible operating or strategic funding bridge reconcile |
| Nasdaq compliance path | Through January 27, 2027 | A reverse-split or other capital-action path increases supply or fails to create durable operating access | The company regains compliance through a sustained bid and shows a credible funding path |
| AI or HPC operating evidence | Any new 6-K, 8-K, customer, or partner filing | The pivot remains narrative-only, without a dollar revenue, margin, or cash bridge | A filed customer, financing, deployment, or revenue disclosure is large enough to change the per-share case |
| Next audited or periodic financial update | Next 10-Q or 20-F | Cash use, losses, and going-concern language remain without operating conversion | Cash flow improves, the financing need falls, and the AI business is independently measurable |
The cheapest disconfirming sequence is: the first actual ATM sale or no-sale disclosure, the next cash and share-count reconciliation, the next Nasdaq compliance filing, and the first filed AI or HPC revenue or funding bridge. This sequence adjudicates supply, liquidity, and the operating counterargument.
The Gap
Observation: CHAI trades below the filing's $0.33 reference while the issuer has described a broad AI and HPC expansion and filed capacity that can represent roughly 43% to 47% of the current common denominator at recent reference prices.
Inference: The stock may be carrying value for an AI pivot that has not yet been connected to revenue, unrestricted cash, or operating cash flow. At the same time, the audited financial statements show a financing-dependent company. This is a price-versus-evidence disagreement, not proof that the pivot has no value.
Unknown: Actual ATM usage, current August cash, current debt, the legal treatment of any pre-funded or other securities not included in the common count, reverse-split terms, borrowability, and the timing of any AI customer or capital disclosure.
The Payoff Map
The payoff map is a price-only short framework. An executable expected value cannot be computed because entry.price is null, borrow and recall economics are missing, same-session market structure is unverified, and the latest audited balance sheet predates the fresh financing. The weighted price is useful only as a conditional comparison against the $0.3192 reference.
Using the scenario map below, the probability-weighted price is $0.2875, implying a price-only expected short return of about 9.9% before borrow fees, locate costs, recall risk, spread, slippage, gap risk, taxes, and the cost of waiting for the next filing. That modest edge is why the correct label is Watchlist, not active trade.
Price Target and Probability Map
For a short, Top means the favorable low-price outcome. Bottom means the squeeze or recovery case. These are judgmental scenarios, not forecasts or personalized financial advice.
| Case | Probability | Target price | Gross short return from $0.3192 | Required condition |
|---|---|---|---|---|
| Top | 25% | $0.12 | +62.4% | An actual ATM sale or other financing increases supply, the next filing shows continued cash dependence, and no AI revenue or strategic funding bridge appears |
| Base | 50% | $0.24 | +24.8% | The ATM remains potential or is only partly used, the pivot produces no measurable cash evidence, and the financing or listing overhang keeps the quote below the filing reference |
| Bottom | 25% | $0.55 | -72.3% | A strategic AI or HPC partner, non-dilutive capital, reverse-split rebound, or sustained bid-price cure creates a squeeze before the cash bridge is settled |
| Probability-weighted price | 100% | $0.2875 | +9.9% price-only expected short return | Before borrow, recall, spread, slippage, gap, and tax costs |
| Fundamental invalidation | n/a | Reassess above $0.55 | n/a | A verified funding and operating bridge supports the AI value, not price alone |
The expected payoff is not large enough to excuse weak execution evidence. A price-only 9.9% edge can be a poor trade if CHAI is hard to borrow, if the quote gaps through the squeeze case, or if the company obtains strategic capital. The scenario map is a research control, not an entry signal.
What Could Go Wrong
| Risk | Evidence or mechanism | Control |
|---|---|---|
| The ATM is unused | The supplement permits sales but does not require any sale or minimum amount | Do not short on capacity alone; wait for a sale, a cash filing, or a separate dated catalyst |
| AI capital arrives | The company is explicitly seeking AI and HPC infrastructure expansion | Put strategic or non-dilutive funding in the bottom case and reassess any partner filing |
| Reverse split or compliance rebound | Nasdaq's initial cure period runs to January 27, 2027 | Treat the listing clock as a squeeze catalyst, not proof of dilution; do not short a corporate-action headline |
| The audited cash is stale | The latest cited cash and operating-cash figures are as of December 31, 2025 | Require the next cash and share-count filing before upgrading the thesis |
| The tape halts or gaps | CHAI is a low-priced microcap and the latest snapshot is outside regular hours | No intraday-low short, no market order, staged limits only after a fresh market-structure review |
| Borrow is unavailable or recalled | Live locate, fee, utilization, recall, and settlement data were not verified | entry.price remains null, execution.can_execute remains false, and no-locate/no-trade applies |
| The denominator is misunderstood | ATM capacity, pre-funded claims, warrants, and actual shares can be different states | Reconcile each instrument in the next filed share count; never call the $3.539M capacity current float |
What Would Prove This Wrong
The short thesis fails fundamentally if the next filings show that Core AI obtained enough unrestricted capital to fund operations without the ATM, produced a material and credible AI or HPC revenue bridge, and preserved or improved the per-share denominator. It also fails if the Nasdaq compliance path is resolved without a financing overhang and the company reports cash flow that materially changes the going-concern evidence.
A price rebound alone is not proof. The kill shot is a reconciled bridge: actual ATM shares, actual cash received, current cash and debt, current common and common-equivalent shares, filed AI or HPC revenue or contracts, and a sustained compliance path. A close above $0.55 alongside that evidence requires a full reassessment. Without the evidence, $0.55 is only a squeeze-control reference.
Counterparty Argument
The best long argument is that CHAI is being valued as a small public platform with access to speculative AI infrastructure capital, not as the legacy operating business in the 20-F. The company may have an option to secure a strategic customer, lease data-center capacity, or use the public listing to fund a new product with much higher future revenue than the audited base. A reverse split could restore a usable quote, and the low nominal price can attract momentum before the filing bridge is visible.
That argument deserves a material bottom-case probability. The prospectus does describe an AI and HPC plan, and the ATM can provide flexibility if the company can sell shares without destroying the market. A clean funding announcement could make the current $0.3192 reference look backward-looking.
The counterargument does not prove the market is wrong. It identifies the exact evidence that would make the short wrong: unrestricted capital, an independently measurable operating contribution, a reconciled denominator, and compliance that survives without an emergency financing. Until those appear, the better claim is conditional financing pressure, not certain failure.
Canonical Rubric
| Rubric | CHAI result |
|---|---|
| Price | $0.3192 after-hours reference versus a $0.33 filing reference and a potential ATM denominator increase of about 43% to 47% |
| Positioning | Fresh financing capacity and active volume are visible, but live short, borrow, options, dealer, fund, spread, depth, venue, and exit data are missing. Score 3/5 |
| Catalyst | First ATM sale or no-sale filing, next cash and share-count reconciliation, Nasdaq cure path, and first filed AI or HPC operating bridge |
| Reality | Latest audited cash of $1.931M, 2025 operating cash use of $6.651M, accumulated deficit of $31.964M, and going-concern language coexist with a new AI and HPC narrative |
| Payoff | Top, base, and bottom prices total 100%; price-only expected short return is positive but modest, and executable EV is unknown |
| Kill shot | Strategic or non-dilutive funding, measurable AI revenue, current cash improvement, a stable denominator, and a sustained Nasdaq compliance path |
Best Trade Strategy
- Direction: Conditional U.S.-listed common-stock short Watchlist.
- Preferred instrument: CHAI common stock only. No options or leverage from this research because the live chain and market structure were not verified.
- Common-stock stance: No execution. Potential supply is a research catalyst, not current float.
- Reference price: $0.3192 at 2026-08-11 21:35:00 UTC. This is not an entry.
- Entry: None verified. Keep
entry.pricenull andexecution.can_executefalse. - Trigger: Require a filed ATM sale or another dated financing event, a verified locate and borrow with acceptable recall terms, and a fresh regular-session review of spread, depth, venue, volume quality, and exit liquidity. Prefer failed continuation after the event. Do not short an intraday low, a halt, or an after-hours print.
- Targets: First cover zone $0.24; deeper cover zone $0.12; squeeze-control reference $0.55.
- Invalidation: Reassess if a verified filing shows unrestricted strategic or non-dilutive funding, measurable AI or HPC revenue, cash-flow improvement, a stable or reduced denominator, and a credible Nasdaq compliance path. Price alone is not a fundamental invalidator.
- Time horizon: The first ATM or financing filing, the next cash and share-count report, and the Nasdaq compliance path through January 27, 2027.
- Options: No options. Live bid-ask width, open interest, implied volatility, dealer positioning, and settlement quality were not verified.
- Execution risks: Low-priced microcap gaps, halts, borrow recall, wide spread, shallow depth, unverified venue quality, weak exit liquidity, reverse-split mechanics, and an AI funding headline can overwhelm a correct supply thesis.
- Do-not-trade conditions: No locate; no borrow; unacceptable recall terms; no fresh regular-session quote; wide or unstable spread; shallow or unreliable depth; weak exit liquidity; halt or disorderly trading; a fresh strategic or non-dilutive funding filing; a material AI customer or revenue disclosure; or any attempt to use options without a verified liquid chain.
- Monitoring checklist: Actual ATM shares and proceeds; current common and common-equivalent shares; cash and operating burn; debt and maturity claims; AI or HPC customers, contracts, deployments, and revenue; Nasdaq compliance notices; reverse-split terms; daily volume; borrow fee, recall, utilization, short interest, options, and exit liquidity.
Bottom Line
CHAI is the best current U.S. short candidate because a fresh ATM can represent about 43% to 47% of the filed common denominator while the latest audited filing still shows a small cash balance, operating cash use, accumulated losses, and going-concern risk. The AI and HPC pivot may be valuable, but the cited filings do not yet connect it to revenue or unrestricted cash. The prospectus capacity is potential supply, not current float.
The price-only map gives a weighted $0.2875 and an expected short return of about 9.9% before borrow and execution costs. That is not permission to trade. The useful next action is to wait for the first actual ATM or cash/share-count disclosure, verify borrow and regular-session liquidity, and reject the short if strategic capital or operating evidence changes the denominator and cash bridge.
Research Quality Scorecard
| Dimension | Score | Reason |
|---|---|---|
| Market disagreement | 5/5 | Separates the AI narrative, ATM capacity, actual cash, filed denominator, and listing clock |
| Evidence base | 5/5 | Fresh 424B5, audited 20-F, current SEC facts, and timestamped market snapshot |
| Positioning and flows | 3/5 | Financing capacity and volume are visible, but live short, borrow, options, dealer, fund, spread, depth, venue, and exit data are missing |
| Catalyst path | 5/5 | First ATM sale, next cash and share-count filing, Nasdaq cure path, and AI operating disclosure are monitorable |
| Payoff architecture | 4/5 | Scenarios are explicit and asymmetric, but the price-only edge is modest and execution-adjusted EV cannot be computed |
| Invalidation discipline | 4/5 | Funding, operating, denominator, and compliance kill shots are explicit |
| Differentiated insight | 5/5 | The key insight is the separation of AI optionality, ATM capacity, actual cash, and listing mechanics |
| Client value | 4/5 | The note gives a falsifiable filing sequence and a fail-closed expression |
| Total | 35/40 | Publishable as a conditional Short Watchlist, not an active execution signal |
Sources
| Source | Use |
|---|---|
| Core AI Holdings August 11, 2026 Form 424B5 | ATM size, sales agent, August 10 reference price, current common count, illustrative potential shares, AI and HPC description, and Nasdaq deficiency |
| Core AI Holdings May 15, 2026 Form 20-F | Audited cash, operating cash use, revenue, accumulated deficit, and going-concern disclosure |
| CHAI Yahoo Finance quote | Latest available price, change, range, volume, and timestamp; this feed is a reference and not an executable quote |
| Edible Garden August 11, 2026 Form 424B5 | Lower-ranked ATM capacity, public-float calculation, and baby-shelf context |
| Edible Garden August 11, 2026 Form 8-K | Lower-ranked equity-distribution agreement and ATM terms |
| Edible Garden March 31, 2026 Form 10-Q | Lower-ranked cash, current liabilities, revenue, operating cash flow, net loss, and going-concern evidence |
| Banzai August 11, 2026 Form 424B5 | Lower-ranked conversion and warrant resale capacity |
| Banzai March 31, 2026 Form 10-Q | Lower-ranked cash, operating cash use, current liabilities, loss, and common denominator |
| BNZI Yahoo Finance quote | Lower-ranked stale reference and volume; the latest available trade predates this run |
| 374Water August 10, 2026 Form 424B5 | Lower-ranked ATM headline versus remaining baby-shelf capacity |
| SCWO Yahoo Finance quote | Lower-ranked price, change, range, volume, and timestamp |
AI Illustration Prompt
Create a restrained, high-value editorial finance illustration for The Mispricing Desk about a microcap AI pivot priced above an unspent equity-funding ceiling. Show an austere institutional filing desk with a graphite prospectus marked "ATM up to $3.539M" and a precise denominator ledger marked "25.867M filed shares". Across the desk, place a small dark glass server corridor labeled by visual implication as "AI / HPC", with no heroic scale or futuristic hype. Between the prospectus and the server corridor, show a transparent measurement gate with four separate compartments labeled "authorization", "shares", "cash", and "revenue", with only the first compartment illuminated. In the background, place a restrained Nasdaq compliance calendar ending "Jan 27, 2027" and a muted bid-price gauge below "$1.00". Add a thin red line comparing "$0.3192 reference" with "$0.33 filing reference", making clear that the financing reference is not a floor. Use charcoal, bone white, deep navy, brushed silver, muted teal, and one controlled red risk accent. The mood should be forensic, sober, luxurious, and unresolved, suitable for a Bloomberg Markets or Barron's cover. Avoid rockets, cartoon money, generic candlestick charts, meme-stock imagery, glowing AI clichés, and claims of certainty. Add a subtle semi-transparent "The Mispricing Desk" watermark in the lower-right corner.